We are live on ! Find out more
GLA

Good Life Advisors Portfolio holdings

AUM $1.6B
1-Year Est. Return 15.83%
This Fund
S&P 500
This Quarter Est. Return
-3.28%
1 Year Est. Return
+15.83%
3 Year Est. Return
+59.98%
5 Year Est. Return
+94.47%
10 Year Est. Return
AUM
$873M
AUM Growth
-$15.5M
Cap. Flow
+$17.8M
Cap. Flow %
2.04%
Top 10 Hldgs %
32.98%
Holding
443
New
30
Increased
232
Reduced
137
Closed
29
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VISN
401
Vistance Networks Inc
VISN
$1.4B
$116K 0.01%
+34,629
New +$142K
AIV
402
Aimco
AIV
$370M
$116K 0.01%
17,000
HIO
403
Western Asset High Income Opportunity Fund
HIO
$331M
$113K 0.01%
30,941
-1
-0% -$4
NAT icon
404
Nordic American Tanker
NAT
$1.43B
$93.1K 0.01%
22,589
+2,213
+11% +$8.84K
GAB icon
405
Gabelli Equity Trust
GAB
$1.76B
$91.3K 0.01%
17,802
+6,425
+56% +$35.3K
JPS
406
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$64.5K 0.01%
10,459
+21
+0.2% +$134
IGR
407
CBRE Global Real Estate Income Fund
IGR
$693M
$64.1K 0.01%
14,241
-1
-0% -$5
UWMC icon
408
UWM Holdings
UWMC
$2.39B
$53.4K 0.01%
+11,000
New +$63.4K
NCV
409
Virtus Convertible & Income Fund
NCV
$380M
$52K 0.01%
4,181
ABCL icon
410
AbCellera Biologics
ABCL
$3.68B
$46K 0.01%
+10,000
New +$60.8K
TLRY icon
411
Tilray
TLRY
$631M
$40.4K ﹤0.01%
1,692
+605
+56% +$14.3K
DNA icon
412
Ginkgo Bioworks
DNA
$469M
$21.7K ﹤0.01%
300
+50
+20% +$4K
LYG icon
413
Lloyds Banking Group
LYG
$85.7B
$21.7K ﹤0.01%
+10,166
New +$22K
GRTX
414
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$5.47K ﹤0.01%
31,250
+20,000
+178% +$24.9K
ANSS
415
DELISTED
Ansys
ANSS
-649
Closed -$214K
AZN icon
416
AstraZeneca
AZN
$252B
-2,574
Closed -$368K
DHR icon
417
Danaher
DHR
$152B
-953
Closed -$203K
ENPH icon
418
Enphase Energy
ENPH
$4.92B
-1,195
Closed -$200K
FINX icon
419
Global X FinTech ETF
FINX
$175M
-28,424
Closed -$627K
FSK icon
420
FS KKR Capital
FSK
$3.39B
-10,659
Closed -$204K
HASI icon
421
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.14B
-8,360
Closed -$209K
IBB icon
422
iShares Biotechnology ETF
IBB
$10.5B
-1,585
Closed -$201K
IQV icon
423
IQVIA
IQV
$43.1B
-916
Closed -$206K
IXN icon
424
iShares Global Tech ETF
IXN
$9.5B
-3,519
Closed -$219K
LIN icon
425
Linde
LIN
$226B
-561
Closed -$214K

Similar funds

Good Life Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Good Life Advisors held 443 positions worth $873M, down 1.7% from $889M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Good Life Advisors's Q3 2023 filing shows 30 new, 232 increased, 137 reduced and 29 closed positions. Its largest new stake was FT Vest S&P 500 Dividend Aristocrats Target Income ETF: 138,373 shares worth $6.83M. The largest sale was First Trust Value Line Dividend Fund, an estimated $14M.

By sector, the portfolio is most concentrated in Miscellaneous at 72% of assets, down from 73% a quarter earlier, followed by Technology and Healthcare.

  • Good Life Advisors's largest Q3 2023 buy was FT Vest S&P 500 Dividend Aristocrats Target Income ETF: 138,373 shares worth $6.83M.
  • Good Life Advisors added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q3 2023, an estimated $7.79M increase.
  • Good Life Advisors's biggest Q3 2023 reduction was First Trust Value Line Dividend Fund, cutting an estimated $14M.
  • Good Life Advisors fully exited Invesco BulletShares 2024 Corporate Bond ETF in Q3 2023, selling an estimated $6.56M.
  • Good Life Advisors's ten largest holdings make up 33% of its $873M portfolio in Q3 2023.
  • Good Life Advisors opened 30 new positions and closed 29 in Q3 2023.
  • Good Life Advisors's portfolio value fell 1.7% quarter-over-quarter to $873M.

Based on Good Life Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.